Hims & Hers Health, Inc. (HIMS) Stock Analysis
By stockpickr AI | February 15, 2026 | 10 min read
Investment Summary
HIMS is a telehealth company offering personalized health and wellness solutions for men and women. Sentiment is cautiously optimistic despite recent revenue growth.
Investment Recommendation
Sell
Fair Value: $2.13
Current Price: $8.59
Upside/Downside: -75.2%
HIMS demonstrates strong revenue growth and expanding market reach in the telehealth sector. Despite current unprofitability, its strategic initiatives and analyst consensus suggest a positive outlook, making it a potentially attractive growth investment.
Key Metrics
- Market Cap: $1.82B
- P/E Ratio: N/A
- Dividend Yield: 0.00%
- Analyst Target Price: $13.20
Strengths
- Strong revenue growth driven by expanding service offerings and customer base.
- Increasing brand recognition and customer loyalty in the competitive telehealth market.
- Leveraging technology to improve patient access and experience.
Risk Factors
- Path to profitability remains uncertain with continued net losses.
- Intense competition from other telehealth providers and traditional healthcare services.
- Regulatory changes in the healthcare and telehealth industry could impact operations.
Latest News
Hims & Hers Health Inc.: Seeking Alpha Quant Rating Downgrade Signals Caution
The article discusses a recent downgrade of Hims & Hers' quant rating, suggesting that investors should exercise caution despite some positive fundamental aspects.
Source: Seeking Alpha | Sentiment: Slightly Negative
Hims & Hers Health Inc. Insider Selling
This news item reports on recent insider selling activity for Hims & Hers stock, which can sometimes be interpreted as a bearish signal by the market.
Source: Investing.com | Sentiment: Slightly Negative
Hims & Hers Health Inc. (NYSE:HIMS) Receives Buy Rating from Wedbush Securities
Wedbush Securities has initiated coverage on Hims & Hers Health with a 'Buy' rating and a $16.00 price target, highlighting its growth potential in the telehealth market.
Source: MarketBeat | Sentiment: Moderately Positive